Haemophilia trials in New Zealand

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

  Where

  Auckland

  Age

  2 years to 59 years

  People

  60 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT05987449 · EU 2023-503906-35-00
• Phase 3Taking people
  A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  Where

  Auckland, Wellington

  Age

  12 years and over

  People

  360 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07416604 · EU 2025-522435-33-00